Common use of Adolor Products in the United States Clause in Contracts

Adolor Products in the United States. Subject to ------------------------------------ reconciliation as provided in Section 6.7.5, Adolor shall be responsible and pay for ** percent (**%) and GSK shall be responsible and pay for ** percent (**%) of the Development Expenses for each Adolor Product for Commercialization in the United States incurred from January 1, 2002 through the First Commercial Sale for such Adolor Product. Thereafter, Development Expenses, if any, for each Adolor Product shall be shared in accordance with **. With respect to the OBD Acute Product, Adolor shall be solely responsible for (and such expenses shall not be deemed Development Expenses) expenses related to the Development of the OBD Acute Product incurred prior to the determination to proceed with the Development of the OBD Acute Product in accordance with Section 4.4.4 other than those expenses associated with clinical study 14CL306 which are set forth in Schedule 1.146. --------------